<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre=": 100120031: Review: Review Article Convalescent plasma therapy: a promising" exact="coronavirus disease 2019" post="treatment strategy Plasma therapy a possible hope to fight"/>
 <result pre="is passing through a very difficult phase due to the" exact="coronavirus disease 2019" post="(COVID-19) pandemic, which has disrupted almost all spheres of"/>
 <result pre="used in the treatment of viral-induced diseases like SARS-CoV epidemics," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) pandemics, Ebola epidemics and H1N1 pandemic. In"/>
 <result pre="like SARS-CoV epidemics, Middle East respiratory syndrome coronavirus (MERS-CoV) pandemics," exact="Ebola" post="epidemics and H1N1 pandemic. In this review, we have"/>
 <result pre="abbreviated the novel coronavirus as SARS-CoV-2, and the new disease" exact="coronavirus disease 2019" post="as COVID-19 [4]. Coronaviruses (CoVs) belong to the family"/>
 <result pre="used by several countries to treat patients suffering from severe" exact="SARS-CoV-2 infection" post="[18,19]. CP has proved its effectiveness in neutralizing viruses"/>
 <result pre="has proved its effectiveness in neutralizing viruses like SARS-CoV, MERS-CoV," exact="Ebola" post="and H1N1. So, in this pandemic situation of COVID-19,"/>
 <result pre="immune response of individuals. Based on the differential response, the" exact="SARS-CoV-2 infection" post="is clinically categorized into mainly two stages [16]: non-severe"/>
 <result pre="to enhance antibody-dependent cellular cytotoxicity, among other effects [67]. After" exact="SARS-CoV infection," post="IgG antibodies are produced in response to the nucleoprotein"/>
 <result pre="the beginning of disease [75]. Even after 2 years of" exact="SARS-CoV infection," post="around 89% of the convalesced patients displayed neutralizing antibodies"/>
 <result pre="been shown that viral infections in the blood, such as" exact="SARS-CoV infection," post="are at their maximum during the first week of"/>
 <result pre="reported the efficacy of CP therapy in curing patients with" exact="SARS-CoV-2 infection" post="[54,85,86]. TableÂ 1 precisely enlists the CP administration in"/>
 <result pre="the clinical outcomes by neutralizing viraemia in patients with critical" exact="SARS-CoV-2 infection" post="and can serve as a promising rescue option for"/>
 <result pre="the CP was advantageous for the severely sick patients of" exact="SARS-CoV-2 infection," post="who were suffering from critical respiratory ailments. The patients"/>
 <result pre="al.2011Convalescent plasma treatment reduced mortality in patients with severe pandemic" exact="Influenza" post="A (H1N1) 2009 virus infection. Clin. Infect. Dis.52, 447â€&quot;456."/>
 <result pre="1268â€&quot;1269. (10.1056/NEJMe2002387)32109011 62GasparyanAY, MisraDP, YessirkepovM, ZimbaO2020Perspectives of immune therapy in" exact="coronavirus disease 2019." post="J. Korean Med. Sci.35, e176 (10.3346/jkms.2020.35.e176)32383371 63BenjaminRJ, McLaughlinLS2012Plasma components:"/>
 <result pre="Microbiol.4, 734â€&quot;747. (10.1038/s41564-019-0392-y)30886356 72Van GriensvenJet al.2016Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in Guinea. N. Engl. J. Med.374, 33â€&quot;42."/>
 <result pre="convalescent whole blood or plasma collected from patients recovered from" exact="Ebola" post="virus disease for transfusion, as an empirical treatment during"/>
 <result pre="lung injury following convalescent plasma transfusion in a patient with" exact="Middle East respiratory syndrome." post="Ann. Lab. Med.36, 393â€&quot;395. (10.3343/alm.2016.36.4.393)27139619 93GuptaSS, GuptaAK, ChandakP, KumariJ2020Convalescent"/>
</results>
